Search Results - "Meulbroek, Jon"

In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosisStrains by Oleksijew, Andy, Meulbroek, Jon, Ewing, Patty, Jarvis, Ken, Mitten, Mike, Paige, Lenette, Tovcimak, Ann, Nukkula, Mike, Chu, Daniel, Alder, Jeffrey D

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens by Ma, Zhenkun, Clark, Richard F, Brazzale, Antony, Wang, Sanyi, Rupp, Michael J, Li, Leping, Griesgraber, George, Zhang, Suoming, Yong, Hong, Phan, Ly Tam, Nemoto, Peter A, Chu, Daniel T. W, Plattner, Jacob J, Zhang, Xiaolin, Zhong, Ping, Cao, Zhensheng, Nilius, Angela M, Shortridge, Virginia D, Flamm, Robert, Mitten, Michael, Meulbroek, Jon, Ewing, Patty, Alder, Jeff, Or, Yat Sun

“…A novel series of erythromycin derivatives has been discovered with potent activity against key respiratory pathogens, including those resistant to…”
Get full text

Total synthesis and antifungal evaluation of cyclic aminohexapeptides by KLEIN, L. L, LEPING LI, KISHORE, V, LUNDELL, E. O, WODKA, D, MEULBROEK, J. A, ALDER, J. D, NILIUS, A. M, LARTEY, P. A, PLATTNER, J. J, CHEN, H.-J, CURTY, C. B, DEGOEY, D. A, GRAMPOVNIK, D. J, LEONE, C. L, THOMAS, S. A, YEUNG, C. M, FUNK, K. W

“…The need for new therapies to treat systemic fungal infections continues to rise. Naturally occurring hexapeptide echinocandin B (1) has shown potent…”
Get full text

In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains by OLEKSIJEW, A, MEULBROEK, J, EWING, P, JARVIS, K, MITTEN, M, PAIGE, L, TOVCIMAK, A, NUKKULA, M, CHU, D, ALDER, J. D

“…Current therapy for pulmonary tuberculosis involves 6 months of treatment with isoniazid, pyrazinamide, rifampin, and ethambutol or streptomycin for reliable…”
Get full text

Enteral formula composition does not affect response to lethal infectious challenge in mice by Alder, J D, Meulbroek, J, Jarvis, K, Mitten, M, Hutch, Sr, T, Paige, L, Shipkowitz, N, Henningfield, M F, Clement, J

“…The effects of enteral formulations on the response of mice to infectious challenge with Listeria monocytogenes, influenza A or Candida albicans were studied…”
Get more information